Literature DB >> 33602593

Advances and unanswered questions in management of acute myeloid leukemia in older adults: A glimpse into the future.

Vijaya Raj Bhatt1.   

Abstract

Entities:  

Keywords:  Acute myeloid leukemia; Geriatric assessment; Older adults; Patient-centered care; Precision oncology; Symptom science

Mesh：

Year:  2021        PMID： 33602593      PMCID： PMC8260436          DOI： 10.1016/j.jgo.2021.02.011

Source DB:  PubMed          Journal:  J Geriatr Oncol        ISSN： 1879-4068            Impact factor:   3.929


× No keyword cloud information.
  29 in total

1.  Targeted next-generation sequencing of circulating cell-free DNA vs bone marrow in patients with acute myeloid leukemia.

Authors:  Nicholas J Short; Keyur P Patel; Maher Albitar; Miguel Franquiz; Rajyalakshmi Luthra; Rashmi Kanagal-Shamanna; Feng Wang; Rita Assi; Guillermo Montalban-Bravo; Jairo Matthews; Wanlong Ma; Sanam Loghavi; Koichi Takahashi; Ghayas C Issa; Steven M Kornblau; Elias Jabbour; Guillermo Garcia-Manero; Hagop M Kantarjian; Zeev Estrov; Farhad Ravandi
Journal:  Blood Adv       Date:  2020-04-28

2.  Results from a multidisciplinary clinic guided by geriatric assessment before stem cell transplantation in older adults.

Authors:  Benjamin A Derman; Keriann Kordas; Jean Ridgeway; Selina Chow; William Dale; Sang Mee Lee; Elingel Aguada; Andrzej J Jakubowiak; Jagoda Jasielec; Justin Kline; Satyajit Kosuri; Richard A Larson; Hongtao Liu; Mylove Mortel; Olatoyosi Odenike; Jennifer Pisano; Peter Riedell; Wendy Stock; Michael R Bishop; Andrew S Artz
Journal:  Blood Adv       Date:  2019-11-26

3.  Molecular mechanisms mediating relapse following ivosidenib monotherapy in IDH1-mutant relapsed or refractory AML.

Authors:  Sung Choe; Hongfang Wang; Courtney D DiNardo; Eytan M Stein; Stéphane de Botton; Gail J Roboz; Jessica K Altman; Alice S Mims; Justin M Watts; Daniel A Pollyea; Amir T Fathi; Martin S Tallman; Hagop M Kantarjian; Richard M Stone; Lynn Quek; Zenon Konteatis; Lenny Dang; Brandon Nicolay; Parham Nejad; Guowen Liu; Vickie Zhang; Hua Liu; Meredith Goldwasser; Wei Liu; Kevin Marks; Chris Bowden; Scott A Biller; Eyal C Attar; Bin Wu
Journal:  Blood Adv       Date:  2020-05-12

4.  Clonal Selection with RAS Pathway Activation Mediates Secondary Clinical Resistance to Selective FLT3 Inhibition in Acute Myeloid Leukemia.

Authors:  Martin Carroll; Catherine C Smith; Alexander E Perl; Christine M McMahon; Timothy Ferng; Jonathan Canaani; Eunice S Wang; Jennifer J D Morrissette; Dennis J Eastburn; Maurizio Pellegrino; Robert Durruthy-Durruthy; Christopher D Watt; Saurabh Asthana; Elisabeth A Lasater; RosaAnna DeFilippis; Cheryl A C Peretz; Lisa H F McGary; Safoora Deihimi; Aaron C Logan; Selina M Luger; Neil P Shah
Journal:  Cancer Discov       Date:  2019-05-14       Impact factor: 39.397

5.  Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation.

Authors:  Richard M Stone; Sumithra J Mandrekar; Ben L Sanford; Kristina Laumann; Susan Geyer; Clara D Bloomfield; Christian Thiede; Thomas W Prior; Konstanze Döhner; Guido Marcucci; Francesco Lo-Coco; Rebecca B Klisovic; Andrew Wei; Jorge Sierra; Miguel A Sanz; Joseph M Brandwein; Theo de Witte; Dietger Niederwieser; Frederick R Appelbaum; Bruno C Medeiros; Martin S Tallman; Jürgen Krauter; Richard F Schlenk; Arnold Ganser; Hubert Serve; Gerhard Ehninger; Sergio Amadori; Richard A Larson; Hartmut Döhner
Journal:  N Engl J Med       Date:  2017-06-23       Impact factor: 91.245

6.  Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML.

Authors:  Courtney D DiNardo; Eytan M Stein; Stéphane de Botton; Gail J Roboz; Jessica K Altman; Alice S Mims; Ronan Swords; Robert H Collins; Gabriel N Mannis; Daniel A Pollyea; Will Donnellan; Amir T Fathi; Arnaud Pigneux; Harry P Erba; Gabrielle T Prince; Anthony S Stein; Geoffrey L Uy; James M Foran; Elie Traer; Robert K Stuart; Martha L Arellano; James L Slack; Mikkael A Sekeres; Christophe Willekens; Sung Choe; Hongfang Wang; Vickie Zhang; Katharine E Yen; Stephanie M Kapsalis; Hua Yang; David Dai; Bin Fan; Meredith Goldwasser; Hua Liu; Sam Agresta; Bin Wu; Eyal C Attar; Martin S Tallman; Richard M Stone; Hagop M Kantarjian
Journal:  N Engl J Med       Date:  2018-06-02       Impact factor: 91.245

7.  Geriatric assessment among older adults receiving intensive therapy for acute myeloid leukemia: Report of CALGB 361006 (Alliance).

Authors:  Heidi D Klepin; Ellen Ritchie; Brittny Major-Elechi; Jennifer Le-Rademacher; Drew Seisler; Libby Storrick; Ben L Sanford; Guido Marcucci; Weiqiang Zhao; Susan A Geyer; Karla V Ballman; Bayard L Powell; Maria R Baer; Wendy Stock; Harvey Jay Cohen; Richard M Stone; Richard A Larson; Geoffrey L Uy
Journal:  J Geriatr Oncol       Date:  2019-10-24       Impact factor: 3.599

8.  Molecular remission and response patterns in patients with mutant-IDH2 acute myeloid leukemia treated with enasidenib.

Authors:  Eytan M Stein; Courtney D DiNardo; Amir T Fathi; Daniel A Pollyea; Richard M Stone; Jessica K Altman; Gail J Roboz; Manish R Patel; Robert Collins; Ian W Flinn; Mikkael A Sekeres; Anthony S Stein; Hagop M Kantarjian; Ross L Levine; Paresh Vyas; Kyle J MacBeth; Alessandra Tosolini; Jason VanOostendorp; Qiang Xu; Ira Gupta; Thomas Lila; Alberto Risueno; Katharine E Yen; Bin Wu; Eyal C Attar; Martin S Tallman; Stéphane de Botton
Journal:  Blood       Date:  2018-12-03       Impact factor: 25.476

9.  Monocytic Subclones Confer Resistance to Venetoclax-Based Therapy in Patients with Acute Myeloid Leukemia.

Authors:  Shanshan Pei; Daniel A Pollyea; Annika Gustafson; Brett M Stevens; Mohammad Minhajuddin; Rui Fu; Kent A Riemondy; Austin E Gillen; Ryan M Sheridan; Jihye Kim; James C Costello; Maria L Amaya; Anagha Inguva; Amanda Winters; Haobin Ye; Anna Krug; Courtney L Jones; Biniam Adane; Nabilah Khan; Jessica Ponder; Jeffrey Schowinsky; Diana Abbott; Andrew Hammes; Jason R Myers; John M Ashton; Travis Nemkov; Angelo D'Alessandro; Jonathan A Gutman; Haley E Ramsey; Michael R Savona; Clayton A Smith; Craig T Jordan
Journal:  Cancer Discov       Date:  2020-01-23       Impact factor: 39.397

10.  Impact of Conditioning Intensity of Allogeneic Transplantation for Acute Myeloid Leukemia With Genomic Evidence of Residual Disease.

Authors:  Christopher S Hourigan; Laura W Dillon; Gege Gui; Brent R Logan; Mingwei Fei; Jack Ghannam; Yuesheng Li; Abel Licon; Edwin P Alyea; Asad Bashey; H Joachim Deeg; Steven M Devine; Hugo F Fernandez; Sergio Giralt; Mehdi Hamadani; Alan Howard; Richard T Maziarz; David L Porter; Bart L Scott; Erica D Warlick; Marcelo C Pasquini; Mitchell E Horwitz
Journal:  J Clin Oncol       Date:  2019-12-20       Impact factor: 44.544
View more
  2 in total

Review 1.  Precision Medicine in Myeloid Malignancies: Hype or Hope?

Authors:  Shristi Upadhyay Banskota; Nabin Khanal; Rosalyn I Marar; Prajwal Dhakal; Vijaya Raj Bhatt
Journal:  Curr Hematol Malig Rep       Date:  2022-08-16       Impact factor: 4.213

2.  Integrating geriatric assessment and genetic profiling to personalize therapy selection in older adults with acute myeloid leukemia.

Authors:  Vijaya R Bhatt; Christopher Wichman; Zaid S Al-Kadhimi; Thuy T Koll; Alfred L Fisher; Ram I Mahato; R Katherine Hyde; Ann Berger; James O Armitage; Sarah A Holstein; Lori J Maness; Krishna Gundabolu
Journal:  J Geriatr Oncol       Date:  2022-04-18       Impact factor: 3.929
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.